Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) EBIT Margin (2016 - 2025)

Nephros has reported EBIT Margin over the past 16 years, most recently at 0.38% for Q4 2025.

  • Quarterly results put EBIT Margin at 0.38% for Q4 2025, down 781.0% from a year ago — trailing twelve months through Dec 2025 was 6.1% (up 606.0% YoY), and the annual figure for FY2025 was 6.1%, up 606.0%.
  • EBIT Margin for Q4 2025 was 0.38% at Nephros, down from 6.59% in the prior quarter.
  • Over the last five years, EBIT Margin for NEPH hit a ceiling of 11.61% in Q1 2025 and a floor of 71.65% in Q1 2022.
  • Median EBIT Margin over the past 5 years was 11.01% (2023), compared with a mean of 17.39%.
  • Biggest five-year swings in EBIT Margin: tumbled -3445bps in 2022 and later soared 6338bps in 2023.
  • Nephros' EBIT Margin stood at 26.58% in 2021, then fell by -2bps to 27.09% in 2022, then increased by 26bps to 19.94% in 2023, then surged by 141bps to 8.19% in 2024, then tumbled by -95bps to 0.38% in 2025.
  • The last three reported values for EBIT Margin were 0.38% (Q4 2025), 6.59% (Q3 2025), and 5.61% (Q2 2025) per Business Quant data.